Lipocine Other Liab from 2010 to 2025
| LPCN Stock | USD 3.54 0.04 1.14% |
Other Liabilities | First Reported 2010-12-31 | Previous Quarter 206.9 K | Current Value 196.5 K | Quarterly Volatility 2.5 M |
Check Lipocine financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Lipocine's main balance sheet or income statement drivers, such as Interest Expense of 0.0, Selling General Administrative of 5.8 M or Total Revenue of 11.8 M, as well as many indicators such as Price To Sales Ratio of 2.21, Dividend Yield of 0.0 or PTB Ratio of 1.3. Lipocine financial statements analysis is a perfect complement when working with Lipocine Valuation or Volatility modules.
Lipocine | Other Liab |
Latest Lipocine's Other Liab Growth Pattern
Below is the plot of the Other Liab of Lipocine over the last few years. It is Lipocine's Other Liabilities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Lipocine's overall financial position and show how it may be relating to other accounts over time.
| Other Liab | 10 Years Trend |
|
Other Liab |
| Timeline |
Lipocine Other Liab Regression Statistics
| Arithmetic Mean | 3,093,647 | |
| Geometric Mean | 1,413,408 | |
| Coefficient Of Variation | 81.59 | |
| Mean Deviation | 2,286,197 | |
| Median | 4,591,200 | |
| Standard Deviation | 2,524,229 | |
| Sample Variance | 6.4T | |
| Range | 7M | |
| R-Value | (0.74) | |
| Mean Square Error | 3.1T | |
| R-Squared | 0.55 | |
| Significance | 0.001 | |
| Slope | (393,504) | |
| Total Sum of Squares | 95.6T |
Lipocine Other Liab History
About Lipocine Financial Statements
Lipocine investors utilize fundamental indicators, such as Other Liab, to predict how Lipocine Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Other Liabilities | 206.9 K | 196.5 K |
Check out the analysis of Lipocine Correlation against competitors. To learn how to invest in Lipocine Stock, please use our How to Invest in Lipocine guide.You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Lipocine. If investors know Lipocine will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Lipocine listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Lipocine is measured differently than its book value, which is the value of Lipocine that is recorded on the company's balance sheet. Investors also form their own opinion of Lipocine's value that differs from its market value or its book value, called intrinsic value, which is Lipocine's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Lipocine's market value can be influenced by many factors that don't directly affect Lipocine's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Lipocine's value and its price as these two are different measures arrived at by different means. Investors typically determine if Lipocine is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Lipocine's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.